Abstract
F1 (SJL/J×C57BL/6) mice with MOG35-55-induced EAE recover from disease when treated with Ig-MOG carrying MOG35-55 peptide. However, Ig-PLP1, carrying PLP139-151, induced reduction of anti-MOG antibodies and exacerbated EAE. Herein, we show that Ig-PLP1 specifically reduces the frequency of B cells producing protective IgG2a/b anti-MOG antibodies. Surprisingly, these cells were marginal zone (MZ), rather than follicular (FO) or newly formed (NF), B cells and transfer of MZ B cells into sick mice nullified disease exacerbation by Ig-PLP1 in a complement dependent manner. These findings reveal a potential self-limiting regulatory mechanism involving auto-antibodies in MOG EAE.
Original language | English |
---|---|
Pages (from-to) | 49-55 |
Number of pages | 7 |
Journal | Journal of Neuroimmunology |
Volume | 266 |
Issue number | 1-2 |
DOIs | |
State | Published - Jan 15 2014 |
Keywords
- Anti-MOG antibodies
- Autoimmunity
- B cells
- EAE
- T cell tolerance